001     302991
005     20250731103553.0
024 7 _ |a 10.1038/s41590-025-02210-x
|2 doi
024 7 _ |a pmid:40670618
|2 pmid
024 7 _ |a 1529-2908
|2 ISSN
024 7 _ |a 1529-2916
|2 ISSN
024 7 _ |a altmetric:179396319
|2 altmetric
037 _ _ |a DKFZ-2025-01438
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Beumer, Niklas
|b 0
245 _ _ |a DNA hypomethylation traits define human regulatory T cells in cutaneous tissue and identify their blood recirculating counterparts.
260 _ _ |a London
|c 2025
|b Springer Nature Limited
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1753950917_19398
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:B330#LA:B330# / 2025 Aug;26(8):1315-1328
520 _ _ |a CD4+ regulatory T (Treg) cells in tissues play crucial immunoregulatory and regenerative roles. Despite their importance, the epigenetics and differentiation of human tissue Treg cells are incompletely understood. Here, we performed genome-wide DNA methylation analysis of human Treg cells from skin and blood and integrated these data into a multiomic framework, including chromatin accessibility and gene expression. This analysis identified programs that governed the tissue adaptation of skin Treg cells. We found that subfamilies of transposable elements represented a major constituent of the hypomethylated landscape in tissue Treg cells. Based on T cell antigen receptor sequence and DNA hypomethylation homologies, our data indicate that blood CCR8+ Treg cells contain recirculating human skin Treg cells. Conversely, differences in chromatin accessibility and gene expression suggest a certain reversal of the tissue adaptation program during recirculation. Our findings provide insights into the biology of human tissue Treg cells, which may help harness these cells for therapeutic purposes.
536 _ _ |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312)
|0 G:(DE-HGF)POF4-312
|c POF4-312
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Imbusch, Charles D
|0 0000-0003-4920-551X
|b 1
|e First author
700 1 _ |a Kaufmann, Tamara
|0 0000-0003-4294-8767
|b 2
700 1 _ |a Schmidleithner, Lisa
|b 3
700 1 _ |a Gütter, Kathrin
|b 4
700 1 _ |a Stüve, Philipp
|b 5
700 1 _ |a Marchel, Harriet
|0 0009-0000-4242-8505
|b 6
700 1 _ |a Weichenhan, Dieter
|0 P:(DE-He78)ff4024f7bc236e7897d9c18ee19c451f
|b 7
|u dkfz
700 1 _ |a Bähr, Marion
|0 P:(DE-He78)cfd12c2b002e4edb674103723a470712
|b 8
|u dkfz
700 1 _ |a Ruhland, Brigitte
|b 9
700 1 _ |a Marini, Federico
|0 0000-0003-3252-7758
|b 10
700 1 _ |a Sanderink, Lieke
|b 11
700 1 _ |a Ritter, Uwe
|b 12
700 1 _ |a Simon, Malte
|0 P:(DE-He78)de4915d76b207d077967848783f8d2ba
|b 13
700 1 _ |a Braband, Kathrin Luise
|b 14
700 1 _ |a Voss, Morten Michael
|b 15
700 1 _ |a Helbich, Sara Salome
|b 16
700 1 _ |a Mihoc, Delia Mihaela
|b 17
700 1 _ |a Hotz-Wagenblatt, Agnes
|0 P:(DE-He78)2f34b89d62d5e5c651aa1e683844b092
|b 18
700 1 _ |a Nassabi, Hadrian
|b 19
700 1 _ |a Eigenberger, Andreas
|b 20
700 1 _ |a Prantl, Lukas
|b 21
700 1 _ |a Gebhard, Claudia
|b 22
700 1 _ |a Rehli, Michael
|b 23
700 1 _ |a Strieder, Nicholas
|0 0000-0003-1183-1099
|b 24
700 1 _ |a Singh, Kartikeya
|b 25
700 1 _ |a Schmidl, Christian
|b 26
700 1 _ |a Plass, Christoph
|0 P:(DE-He78)4301875630bc997edf491c694ae1f8a9
|b 27
|u dkfz
700 1 _ |a Huehn, Jochen
|0 0000-0001-8071-1379
|b 28
700 1 _ |a Hehlgans, Thomas
|b 29
700 1 _ |a Polansky, Julia K
|0 0000-0003-4727-2540
|b 30
700 1 _ |a Brors, Benedikt
|0 P:(DE-He78)fc949170377b58098e46141d95c72661
|b 31
|e Last author
|u dkfz
700 1 _ |a Delacher, Michael
|b 32
700 1 _ |a Feuerer, Markus
|b 33
773 _ _ |a 10.1038/s41590-025-02210-x
|0 PERI:(DE-600)2026412-4
|n 8
|p 1315-1328
|t Nature immunology
|v 26
|y 2025
|x 1529-2908
909 C O |p VDB
|o oai:inrepo02.dkfz.de:302991
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 0000-0003-4920-551X
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)ff4024f7bc236e7897d9c18ee19c451f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)cfd12c2b002e4edb674103723a470712
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)de4915d76b207d077967848783f8d2ba
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 18
|6 P:(DE-He78)2f34b89d62d5e5c651aa1e683844b092
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 27
|6 P:(DE-He78)4301875630bc997edf491c694ae1f8a9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 31
|6 P:(DE-He78)fc949170377b58098e46141d95c72661
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-312
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Funktionelle und strukturelle Genomforschung
|x 0
914 1 _ |y 2025
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2024-12-13
|w ger
915 _ _ |a DEAL Nature
|0 StatID:(DE-HGF)3003
|2 StatID
|d 2024-12-13
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT IMMUNOL : 2022
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-13
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-13
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-13
915 _ _ |a IF >= 30
|0 StatID:(DE-HGF)9930
|2 StatID
|b NAT IMMUNOL : 2022
|d 2024-12-13
920 2 _ |0 I:(DE-He78)B330-20160331
|k B330
|l Angewandte Bioinformatik
|x 0
920 1 _ |0 I:(DE-He78)B370-20160331
|k B370
|l Epigenomik
|x 0
920 1 _ |0 I:(DE-He78)W610-20160331
|k W610
|l Core Facility Omics IT
|x 1
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 2
920 1 _ |0 I:(DE-He78)B330-20160331
|k B330
|l Angewandte Bioinformatik
|x 3
920 0 _ |0 I:(DE-He78)B330-20160331
|k B330
|l Angewandte Bioinformatik
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B370-20160331
980 _ _ |a I:(DE-He78)W610-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a I:(DE-He78)B330-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21